Investing.com - Biofrontera ADR reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Biofrontera ADR announced earnings per share of $-0.93 on revenue of $11.8M. Analysts polled by Investing.com anticipated EPS of $-0.55 on revenue of $10.72M.
Biofrontera ADR shares are down 10.1% from the beginning of the year and are trading at $2.670 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Biofrontera ADR follows other major Healthcare sector earnings this month
Biofrontera ADR's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar